Qpex opens phase I study of QPX-9003 for infections caused by drug-resistant Gram-negative pathogens June 18, 2021
Modus collaborates with Imperial College London on clinical study of sevuparin in malaria June 18, 2021
Daiichi Sankyo discontinues development of nafamostat inhalation formulation for COVID-19 in Japan June 16, 2021
RSS